Dietary flaxseed administered post thoracic radiation treatment improves survival and mitigates radiation-induced pneumonopathy in mice

BMC Cancer

Melpo Christofidou-Solomidou⁴  Sonia Tyagi⁴  Kay-See Tan¹  Sarah Hagan³  Ralph Pietrofesa⁴  Floyd Dukes⁴  Evguenia Arguiri⁴  Daniel F Heitjan¹  Charalambos C Solomides²  Keith A Cengel³ 

[1] Biostatistics & Epidemiology, University of Pennsylvania Medical Center, Philadelphia, PA 19104, USA

[2] Department of Pathology, Jefferson University Hospital, Philadelphia, PA 19140, USA

[3] Radiation Oncology, University of Pennsylvania Medical Center, Philadelphia, PA 19104, USA

[4] Department of Medicine, Pulmonary Allergy and Critical Care Division, University of Pennsylvania Medical Center, Philadelphia, PA 19104, USA

关键词: mouse model;    cytokines;    survival;    bronchoalveolar lavage;    inflammation;    ROS;    lung injury;    SDG;    flaxseed lignans;    antioxidant;    lung fibrosis;    mitigation;    radiation pneumonopathy;    Flaxseed;   

Others  :  1080866
DOI  :  10.1186/1471-2407-11-269

 received in 2011-02-14, accepted in 2011-06-24,  发布年份 2011

【 摘 要 】

Background

Flaxseed (FS) is a dietary supplement known for its antioxidant and anti-inflammatory properties. Radiation exposure of lung tissues occurs either when given therapeutically to treat intrathoracic malignancies or incidentally, such as in the case of exposure from inhaled radioisotopes released after the detonation of a radiological dispersion devise (RDD). Such exposure is associated with pulmonary inflammation, oxidative tissue damage and irreversible lung fibrosis. We previously reported that dietary FS prevents pneumonopathy in a rodent model of thoracic X-ray radiation therapy (XRT). However, flaxseed's therapeutic usefulness in mitigating radiation effects post-exposure has never been evaluated.

Methods

We evaluated the effects of a 10%FS or isocaloric control diet given to mice (C57/BL6) in 2 separate experiments (n = 15-25 mice/group) on 0, 2, 4, 6 weeks post a single dose 13.5 Gy thoracic XRT and compared it to an established radiation-protective diet given preventively, starting at 3 weeks prior to XRT. Lungs were evaluated four months post-XRT for blood oxygenation levels, inflammation and fibrosis.

Results

Irradiated mice fed a 0%FS diet had a 4-month survival rate of 40% as compared to 70-88% survival in irradiated FS-fed mouse groups. Additionally, all irradiated FS-fed mice had decreased fibrosis compared to those fed 0%FS. Lung OH-Proline content ranged from 96.5 ± 7.1 to 110.2 ± 7.7 μg/ml (Mean ± SEM) in all irradiated FS-fed mouse groups, as compared to 138 ± 10.8 μg/ml for mice on 0%FS. Concomitantly, bronchoalveolar lavage (BAL) protein and weight loss associated with radiation cachexia was significantly decreased in all FS-fed groups. Inflammatory cell influx to lungs also decreased significantly except when FS diet was delayed by 4 and 6 weeks post XRT. All FS-fed mice (irradiated or not), maintained a higher blood oxygenation level as compared to mice on 0%FS. Similarly, multiplex cytokine analysis in the BAL fluid revealed a significant decrease of specific inflammatory cytokines in FS-fed mice.

Conclusions

Dietary FS given post-XRT mitigates radiation effects by decreasing pulmonary fibrosis, inflammation, cytokine secretion and lung damage while enhancing mouse survival. Dietary supplementation of FS may be a useful adjuvant treatment mitigating adverse effects of radiation in individuals exposed to inhaled radioisotopes or incidental radiation.

【 授权许可】

   
2011 Christofidou-Solomidou et al; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

Figure 7.

Figure 8.

Figure 9.

【 参考文献 】

• [1]Brenner DJ, Hall EJ: Computed tomography--an increasing source of radiation exposure. N Engl J Med 2007, 357(22):2277-2284.
• [2]Vogel H: Rays as weapons. Eur J Radiol 2007, 63(2):167-177.
• [3]Chin FK: Scenario of a dirty bomb in an urban environment and acute management of radiation poisoning and injuries. Singapore Med J 2007, 48(10):950-957.
• [4]Dombroski MJ, Fischbeck PS: An integrated physical dispersion and behavioral response model for risk assessment of radiological dispersion device (RDD) events. Risk Anal 2006, 26(2):501-514.
• [5]Moulder JE: Post-irradiation approaches to treatment of radiation injuries in the context of radiological terrorism and radiation accidents: a review. Int J Radiat Biol 2004, 80(1):3-10.
• [6]Machtay M: Pulmonary complications of anticancer treatment. 3rd edition. Churchill Livingston; 2003.
• [7]Marks LB, Yu X, Vujaskovic Z, Small W Jr, Folz R, Anscher MS: Radiation-induced lung injury. Semin Radiat Oncol 2003, 13(3):333-345.
• [8]Keane T, Van Dyk J, Rider W: Idiopathic interstitial pneumonia following bone marrow transplantation. Int J Radiat Oncol Biol Phys 1981, 7:1365-1370.
• [9]Franko AJ, Sharplin J: Development of fibrosis after lung irradiation in relation to inflammation and lung function in a mouse strain prone to fibrosis. Radiat Res 1994, 140:347-355.
• [10]Machtay M, Scherpereel A, Santiago J, Lee J, McDonough J, Kinniry P, Arguiri E, Shuvaev VV, Sun J, Cengel K, Solomides CC, Christofidou-Solomidou M: Systemic polyethylene glycol-modified (PEGylated) superoxide dismutase and catalase mixture attenuates radiation pulmonary fibrosis in the C57/bl6 mouse. Radiother Oncol 2006, 81(2):196-205.
• [11]Lee JC, Bhora F, Sun J, Cheng G, Arguiri E, Solomides CC, Chatterjee S, Christofidou-Solomidou M: Dietary flaxseed enhances antioxidant defenses and is protective in a mouse model of lung ischemia-reperfusion injury. Am J Physiol Lung Cell Mol Physiol 2008, 294(2):L255-265.
• [12]Travis EL, Parkins CS, Holmes SJ, Down JD, Fowler JF: WR-2721 protection of pneumonitis and fibrosis in mouse lung after single doses of x-rays. Int J Radiat Oncol Biol Phys 1984, 13:1355-1359.
• [13]Travis EL, Newman RA, Helbing SJ: WR 2721 modification of type II cell and endothelial cell function in mouse lung after single doses of radiation. Int J Radiat Oncol Biol Phys 1987, 13:1355-1359.
• [14]Epperly M, Bray J, Kraeger S, Zwacka R, Engelhardt J, Travis E, Greenberger J: Prevention of late effects of irradiation lung damage by manganese superoxide dismutase gene therapy. Gene Ther 1998, 5(2):196-208.
• [15]Chen Y, Okunieff P: Radiation and third-generation chemotherapy. Hematol Oncol Clin North Am 2004, 18(1):55-80.
• [16]Reboul FL: Radiotherapy and chemotherapy in locally advanced non-small cell lung cancer: preclinical and early clinical data. Hematol Oncol Clin North Am 2004, 18(1):41-53.
• [17]Citrin D, Cotrim AP, Hyodo F, Baum BJ, Krishna MC, Mitchell JB: Radioprotectors and mitigators of radiation-induced normal tissue injury. Oncologist 2010, 15(4):360-371.
• [18]Dileto CL, Travis EL: Fibroblast radiosensitivity in vitro and lung fibrosis in vivo: comparison between a fibrosis-prone and fibrosis-resistant mouse strain. Radiat Res 1996, 146(1):61-67.
• [19]Sharplin J, Franko AJ: A quantitative histological study of strain-dependent differences in the effects of irradiation on mouse lung during the early phase. Radiat Res 1989, 119(1):1-14.
• [20]Kinniry P, Amrani Y, Vachani A, Solomides CC, Arguiri E, Workman A, Carter J, Christofidou-Solomidou M: Dietary flaxseed supplementation ameliorates inflammation and oxidative tissue damage in experimental models of acute lung injury in mice. J Nutr 2006, 136(6):1545-1551.
• [21]Lee JC, Kinniry PA, Arguiri E, Serota M, Kanterakis S, Chatterjee S, Solomides CC, Javvadi P, Koumenis C, Cengel KA, Christofidou-Solomidou M: Dietary curcumin increases antioxidant defenses in lung, ameliorates radiation-induced pulmonary fibrosis, and improves survival in mice. Radiat Res 2010, 173(5):590-601.
• [22]Lee JC, Krochak R, Blouin A, Kanterakis S, Chatterjee S, Arguiri E, Vachani A, Solomides CC, Cengel KA, Christofidou-Solomidou M: Dietary flaxseed prevents radiation-induced oxidative lung damage, inflammation and fibrosis in a mouse model of thoracic radiation injury. Cancer Biol Ther 2009, 8(1):47-53.
• [23]Esterbauer H, Schaur RJ, Zollner H: Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 1991, 11(1):81-128.
• [24]Verhoeven D, Teijaro JR, Farber DL: Pulse-oximetry accurately predicts lung pathology and the immune response during influenza infection. Virology 2009, 390(2):151-156.
• [25]Woessner JF Jr: The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys 1961, 93:440-447.
• [26]Zhang R, Ghosh SN, Zhu D, North PE, Fish BL, Morrow NV, Lowry T, Nanchal R, Jacobs ER, Moulder JE, Medhora M: Structural and functional alterations in the rat lung following whole thoracic irradiation with moderate doses: injury and recovery. Int J Radiat Biol 2008, 84(6):487-497.
• [27]Chiang CS, Liu WC, Jung SM, Chen FH, Wu CR, McBride WH, Lee CC, Hong JH: Compartmental responses after thoracic irradiation of mice: strain differences. Int J Radiat Oncol Biol Phys 2005, 62(3):862-871.
• [28]Morgan GW, Pharm B, Breit SN: Radiation and the lung: A reevaluation of the mechanisms mediating pulmonary injury. Int J Radiat Oncol Biol Phys 1995, 31:361-369.
• [29]Muggenburg BA, Boecker BB, Hahn FF, McClellan RO: Lung lavage therapy to lessen the biological effects of inhaled 144Ce in dogs. Radiat Res 1990, 124(2):147-155.
• [30]Dwivedi C, Natarajan K, Matthees DP: Chemopreventive effects of dietary flaxseed oil on colon tumor development. Nutr Cancer 2005, 51(1):52-58.
• [31]Thompson LU, Rickard SE, Orcheson LJ, Seidl MM: Flaxseed and its lignan and oil components reduce mammary tumor growth at a late stage of carcinogenesis. Carcinogenesis 1996, 17(6):1373-1376.
• [32]Bloedon LT, Szapary PO: Flaxseed and cardiovascular risk. Nutr Rev 2004, 62(1):18-27.
• [33]Rodriguez-Leyva D, Dupasquier CM, McCullough R, Pierce GN: The cardiovascular effects of flaxseed and its omega-3 fatty acid, alpha-linolenic acid. Can J Cardiol 2010, 26(9):489-496.
• [34]Jia D, Koonce NA, Griffin RJ, Jackson C, Corry PM: Prevention and mitigation of acute death of mice after abdominal irradiation by the antioxidant N-acetyl-cysteine (NAC). Radiat Res 2010, 173(5):579-589.
• [35]Rwigema JC, Beck B, Wang W, Doemling A, Epperly MW, Shields D, Goff JP, Franicola D, Dixon T, Frantz MC, Wipf P, Tyurina Y, Kagan VE, Wang H, Greenberger JS: Two strategies for the development of mitochondrion-targeted small molecule radiation damage mitigators. Int J Radiat Oncol Biol Phys 2011, 80(3):860-868.
• [36]Bhatia AL, Jain M: Spinacia oleracea L. protects against gamma radiations: a study on glutathione and lipid peroxidation in mouse liver. Phytomedicine 2004, 11(7-8):607-615.
• [37]Gauter-Fleckenstein B, Fleckenstein K, Owzar K, Jiang C, Reboucas JS, Batinic-Haberle I, Vujaskovic Z: Early and late administration of MnTE-2-PyP5+ in mitigation and treatment of radiation-induced lung damage. Free Radic Biol Med 2010, 48(8):1034-1043.
• [38]Park KJ, Oh YT, Kil WJ, Park W, Kang SH, Chun M: Bronchoalveolar lavage findings of radiation induced lung damage in rats. J Radiat Res (Tokyo) 2009, 50(3):177-182.
• [39]Rubin P, Johnston CJ, Williams JP, McDonald S, Finkelstein JN: A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis. Int J Radiat Oncol Biol Phys 1995, 33(1):99-109.
• [40]Travis EL, Harley RA, Fenn JO, Klobukowski CJ, Hargrove HB: Pathologic changes in the lung following single and multi-fraction irradiation. Int J Radiat Oncol Biol Phys 1977, 2(5-6):475-490.
• [41]Ao X, Zhao L, Davis MA, Lubman DM, Lawrence TS, Kong FM: Radiation produces differential changes in cytokine profiles in radiation lung fibrosis sensitive and resistant mice. J Hematol Oncol 2009, 2:6. BioMed Central Full Text
• [42]Vujaskovic Z, Anscher MS, Feng QF, Rabbani ZN, Amin K, Samulski TS, Dewhirst MW, Haroon ZA: Radiation-induced hypoxia may perpetuate late normal tissue injury. Int J Radiat Oncol Biol Phys 2001, 50(4):851-855.